Guaifenesin (API) Market
- 2026 年市場規模
- USD 94.7 Mn
- 2033 年預估規模
- USD 128.6 Mn
- 年複合成長率 CAGR
- 4.5%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Guaifenesin (API) Market, By Formulation Type (Standard Release and Extended Release), By Application (Cough Syrups and Expectorants, Tablets and Capsules, Combination Respiratory Drugs, and Others), By End User (Pharmaceutical Manufacturers, OTC Healthcare Manufacturers, Contract Manufacturing Organizations (CMOs), and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
報告摘要
The global guaifenesin (API) market is estimated to be valued at USD 94.7 Mn in 2026 and is expected to reach USD 128.6 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 4.5% from 2026 to 2033. Guaifenesin API is an active pharmaceutical ingredient that finds wide applications in the pharmaceutical manufacturing industry around the world. It acts as the active therapeutic ingredient in various expectorant medications formulated to combat respiratory problems. As a mucolytic agent, the Guaifenesin API helps in the fast removal of mucous from the respiratory system. The global guaifenesin (API) market has experienced strong growth over the past few years. This growth can be attributed to the increasing awareness of respiratory issues and related health problems as well as the rapid expansion of pharmaceutical manufacturing infrastructure in emerging economies.
The global guaifenesin (API) market comprises of the pharmaceutical, food and industrial grades of Guaifenesin API. The pharmaceutical grade market accounts for the largest share in the global guaifenesin (API) market owing to the high stringent regulations and quality standards imposed in this regard. The global guaifenesin (API) market is significantly impacted by the seasonal demand pattern, regulatory compliance costs, prices of raw materials and breakthroughs in API manufacturing technology. Leading players in the global guaifenesin (API) market are major pharmaceutical ingredients manufacturers, contract manufacturing organizations and API manufacturers. The competitive positioning of these players is based on the quality, adherence to regulations, costs and dependability of supply of the product. Guaifenesin API as a pharmaceutical active ingredient plays an important role in mitigating the effects of respiratory health issues around the world.
Market Dynamics
The global guaifenesin (API) market is characterized by healthy growth momentum supported by a number of attractive market drivers, such as the rising incidence of respiratory diseases around the globe leading to a sustained demand for expectorants containing guaifenesin API; the aging population, which due to deteriorating health conditions, is more likely to suffer from respiratory diseases requiring pharmaceutical interventions; the increasing awareness among masses, which boosts self-medication and OTC consumption; and others.
However, a number of important restraining factors such as regulatory challenges posed by regulatory authorities including U.S. FDA, EMA and others, raw material price fluctuation, intense price wars among generic manufacturing players in developing markets, patent expiry of the API, and others, create pricing pressure and limit growth opportunities of the market. Nevertheless, considerable opportunities exist in the form of expanding manufacturing capacities in developing countries for low-cost manufacturing, introduction of novel combination formulations including guaifenesin API, increasing demand for high quality APIs in regulated markets, and others.
Key Features of the Study
• This report provides in-depth analysis of the global guaifenesin (API) market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global guaifenesin (API) market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Granules India Limited, Synthokem Labs Pvt. Ltd., LGM Pharma, Sanofi, Transo-Pharm USA LLC, Chunghwa Chemical Synthesis & Biotech Co., Ltd., Tenatra Exports, Gennex Laboratories Limited, Haizhou Pharma, and Delta Synthetic Co.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global guaifenesin (API) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global guaifenesin (API) market
Market Segmentation
• Formulation Type Insights (Revenue, USD Mn, 2021 - 2033)
o Standard Release
o Extended Release
• Application Insights (Revenue, USD Mn, 2021 - 2033)
o Cough Syrups and Expectorants
o Tablets and Capsules
o Combination Respiratory Drugs
o Others
• End User Insights (Revenue, USD Mn, 2021 - 2033)
o Pharmaceutical Manufacturers
o OTC Healthcare Manufacturers
o Contract Manufacturing Organizations (CMOs)
o Others
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o Granules India Limited
o Synthokem Labs Pvt. Ltd.
o LGM Pharma
o Sanofi
o Transo-Pharm USA LLC
o Chunghwa Chemical Synthesis & Biotech Co., Ltd.
o Tenatra Exports
o Gennex Laboratories Limited
o Haizhou Pharma
o Delta Synthetic Co.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Global Guaifenesin (API) Market, By Formulation Type
Global Guaifenesin (API) Market, By Application
Global Guaifenesin (API) Market, By End User
Global Guaifenesin (API) Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Product Launches/Approvals
o PEST Analysis
o PORTER’s Analysis
o Market Opportunities
o Regulatory Scenario
o Key Developments
o Industry Trends
4. Global Guaifenesin (API) Market, By Formulation Type, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Standard Release
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Extended Release
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Guaifenesin (API) Market, By Application, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Cough Syrups and Expectorants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Tablets and Capsules
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Combination Respiratory Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Guaifenesin (API) Market, By End User, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Pharmaceutical Manufacturers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o OTC Healthcare Manufacturers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Contract Manufacturing Organizations (CMOs)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Guaifenesin (API) Market, By Region, 2021 - 2033, Value (USD Mn)
o Introduction
Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
Regional Trends
o North America
Introduction
Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Germany
o U.K.
o Spain
o France
o Italy
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
o South Africa
o North Africa
o Central Africa
8. Competitive Landscape
o Granules India Limited
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Synthokem Labs Pvt. Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o LGM Pharma
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Sanofi
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Transo-Pharm USA LLC
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Chunghwa Chemical Synthesis & Biotech Co., Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Tenatra Exports
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Gennex Laboratories Limited
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Haizhou Pharma
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Delta Synthetic Co.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
9. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
10. References and Research Methodology
o References
o Research Methodology
o About us
*Browse 32 market data tables and 28 figures on ‘Guaifenesin (API) Market' - Global forecast to 2033
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們